These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25075840)

  • 21.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine-resistant malaria in Malawi.
    Kobbe R; Meyer CG; May J
    N Engl J Med; 2007 Feb; 356(8):868; author reply 869. PubMed ID: 17314350
    [No Abstract]   [Full Text] [Related]  

  • 23. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 26. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa.
    Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP
    Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of malaria acquired in Southeast Asia.
    Shanks D; Boslego J
    Mil Med; 1992 Jan; 157(1):4-6. PubMed ID: 1603377
    [No Abstract]   [Full Text] [Related]  

  • 30. K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.
    Torrentino-Madamet M; Collet L; Lepère JF; Benoit N; Amalvict R; Ménard D; Pradines B
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7878-81. PubMed ID: 26416865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisinin resistance in Plasmodium falciparum malaria.
    Htut ZW
    N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular markers of chloroquine resistance in Plasmodium falciparum in Sri Lanka: frequency before revision of the antimalarial drug policy.
    Hapuarachchi HC; Abeysundara S; Dayanath MY; Manamperi A; Abeyewickreme W; de Silva NR
    Ann Trop Med Parasitol; 2009 Jun; 103(4):351-6. PubMed ID: 19508753
    [No Abstract]   [Full Text] [Related]  

  • 33. Modeling to guide drug policy response to artemisinin-resistant malaria in Rwanda.
    Nat Med; 2023 Nov; 29(11):2716-2717. PubMed ID: 37821688
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
    Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM
    Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges of drug-resistant malaria.
    Sinha S; Medhi B; Sehgal R
    Parasite; 2014; 21():61. PubMed ID: 25402734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of malarial infections and disease in Papua New Guinean children.
    Michon P; Cole-Tobian JL; Dabod E; Schoepflin S; Igu J; Susapu M; Tarongka N; Zimmerman PA; Reeder JC; Beeson JG; Schofield L; King CL; Mueller I
    Am J Trop Med Hyg; 2007 Jun; 76(6):997-1008. PubMed ID: 17556601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
    Sisowath C; Strömberg J; Mårtensson A; Msellem M; Obondo C; Björkman A; Gil JP
    J Infect Dis; 2005 Mar; 191(6):1014-7. PubMed ID: 15717281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two advances: fighting resistant malaria and African meningitis].
    Nau JY
    Rev Med Suisse; 2013 Sep; 9(399):1746-7. PubMed ID: 24163883
    [No Abstract]   [Full Text] [Related]  

  • 39. A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia.
    Bayih AG; Getnet G; Alemu A; Getie S; Mohon AN; Pillai DR
    Am J Trop Med Hyg; 2016 Jan; 94(1):132-5. PubMed ID: 26483118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malaria resistance to non-artemisinin partner drugs: how to reACT.
    van Schalkwyk DA; Sutherland CJ
    Lancet Infect Dis; 2015 Jun; 15(6):621-3. PubMed ID: 25877961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.